Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.082 AUD | -1.20% | -2.38% | -25.45% |
Mar. 18 | PYC Therapeutics Raises AU$40 Million via Entitlement Offer | MT |
Mar. 14 | PYC Therapeutics to Raise Up to AU$75 Million for Advancing Drug Candidates | MT |
Sales 2024 * | 8M 5.22M | Sales 2025 * | 8M 5.22M | Capitalization | 347M 227M |
---|---|---|---|---|---|
Net income 2024 * | -31M -20.23M | Net income 2025 * | -34M -22.19M | EV / Sales 2024 * | 38.3 x |
Net cash position 2024 * | 40.79M 26.62M | Net cash position 2025 * | 75.26M 49.11M | EV / Sales 2025 * | 34 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-10.7
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.14% |
Latest transcript on PYC Therapeutics Limited
1 day | -1.20% | ||
1 week | -2.38% | ||
Current month | +3.80% | ||
1 month | -1.20% | ||
3 months | -25.45% | ||
6 months | +36.67% | ||
Current year | -25.45% |
Managers | Title | Age | Since |
---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 40 | - |
Andrew Taylor
DFI | Director of Finance/CFO | - | - |
Kevin Hart
DFI | Director of Finance/CFO | 62 | 17-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 21-03-16 | |
Jason Haddock
BRD | Director/Board Member | 54 | 21-03-28 |
Alan W. Tribe
CHM | Chairman | 76 | 18-04-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.082 | -1.20% | 1,710,042 |
24-03-27 | 0.083 | +2.47% | 700,058 |
24-03-26 | 0.081 | -1.22% | 1,907,312 |
24-03-25 | 0.082 | -2.38% | 1,852,415 |
24-03-22 | 0.084 | 0.00% | 436,808 |
Delayed Quote Australian S.E., March 27, 2024 at 09:59 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.45% | 226M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |